rethinkTHC Search
Menu
Study breakdown

Tobacco and Cannabis Smoke Are Both Linked to Lower Dopamine Receptor Levels

Cross SectionalPreliminary evidence
The takeaway

People who tested positive for tobacco and/or cannabis metabolites had 13% lower striatal dopamine D2 receptor availability on PET imaging, particularly in the nucleus accumbens and putamen.

Addiction researchers, neuroscientists, people interested in how smoking affects the brain, and clinicians advising on cannabis consumption methods.

What the researchers found

Individuals positive for urine metabolites of tobacco and/or cannabis had an average 13.1% lower D2 receptor availability across all striatal subregions compared to negative individuals, with the most significant differences in reward-related brain areas.

Why it matters

Lower D2 receptors in reward circuits are associated with addiction vulnerability and reduced reward sensitivity. Finding that both tobacco and cannabis smoke lower D2 availability suggests shared mechanisms of combustible smoke impact on the brain's reward system.

The numbers in context

29 participants. 13.1% average lower D2 BPND in analyte-positive group (range: 6.6-20.0%). Significant differences in nucleus accumbens and putamen. No effects of alcohol use disorder.

How the study worked

Cross-sectional PET imaging study using [11C]raclopride in 29 participants, comparing striatal D2 receptor availability between those with quantified positive vs. negative urine metabolites for nicotine (cotinine) and THC (THCA).

What this study cannot tell us

Very small sample of 29. Cross-sectional design cannot determine if low D2 preceded or resulted from substance use. Cannot separate tobacco from cannabis effects within the positive group.

How to read the evidence

Novel use of biomarker-verified exposure improves on self-report studies, but very small sample limits confidence in the findings.

When this study was published

Recent study introducing objective metabolite verification to PET imaging research on substance effects on dopamine systems.

The bigger picture

This study uniquely uses objective biomarkers (urine metabolites) rather than self-report to classify smoke exposure, revealing that combustible smoke products — regardless of source — may share neurotoxic effects on dopamine systems.

Questions still open

  • Do non-combusted cannabis products (edibles, vapes) also affect D2 receptors? Are the D2 changes reversible with smoking cessation?

Common questions

Does smoking cannabis lower dopamine receptors?
This small PET study found 13% lower D2 receptor availability in people positive for tobacco and/or cannabis metabolites. The study couldn't separate the effects of each substance, but both involve combustible smoke.
What does lower D2 availability mean?
D2 receptors are part of the brain's reward system. Lower availability may mean reduced reward sensitivity, which is associated with seeking more intense stimulation and potentially addiction vulnerability.

Read the original research

Lower striatal dopamine D2 receptor availability in individuals who test positive for quantitated urine metabolites of tobacco and/or marijuana smoke.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco

Citation

Yoder, Karmen K; Carpenter, Samantha; Hile, Karen L; Dzemidzic, Mario; Durazzo, Timothy C. (2025). Lower striatal dopamine D2 receptor availability in individuals who test positive for quantitated urine metabolites of tobacco and/or marijuana smoke.. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. https://doi.org/10.1093/ntr/ntaf249

Explore the wider topic